The cancer survival index: Measuring progress in cancer survival to help evaluate cancer control efforts in Canada.

IF 2.7 2区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Health Reports Pub Date : 2021-09-15 DOI:10.25318/82-003-x202100900002-eng

Larry F Ellison

{"title":"The cancer survival index: Measuring progress in cancer survival to help evaluate cancer control efforts in Canada.","authors":"Larry F Ellison","doi":"10.25318/82-003-x202100900002-eng","DOIUrl":null,"url":null,"abstract":"Background: A comprehensive evaluation of progress in cancer survival for all cancer types combined has not previously been conducted for Canada. The cancer survival index (CSI) is superior to age standardization in measuring such progress.Data and methods: Data are from the population-based Canadian Cancer Registry, record-linked to the Canadian Vital Statistics Death database. CSI estimates for both sexes combined were calculated as the weighted sum of the sex- and cancer-specific age-standardized net survival estimates. Sex-specific CSI estimates were calculated separately using sex-specific cancer type weights.Results: From the 1992-to-1994 period to the 2015-to-2017 period, the five-year CSI increased 8.6 percentage points to 63.7%. It increased by 8.9 percentage points to 61.8% among males, and by 8.2 percentage points to 65.8% among females. The contribution of a cancer and sex combination to change in the CSI over time is a function of its assigned weight and changes in its age-standardized net survival. Female breast was the most influential cancer and sex combination, contributing 10.1% to the overall increase, followed by prostate (8.2%) and female lung (7.3%). The increase in the index since the 2005-to-2007 period was most impacted by lung cancer among both females (11.1%) and males (9.4%). While prostate cancer survival increased over the entire study period, it has recently decreased, resulting in a counterproductive 8.1% contribution since the 2005-to-2007 period.Interpretation: Steady progress has been made in overall cancer survival in Canada since the early 1990s. Female breast cancer has contributed the most to this progress overall, but more recently female lung cancer has been the most influential.","PeriodicalId":49196,"journal":{"name":"Health Reports","volume":"32 9","pages":"14-26"},"PeriodicalIF":2.7000,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25318/82-003-x202100900002-eng","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 5

Abstract

Background: A comprehensive evaluation of progress in cancer survival for all cancer types combined has not previously been conducted for Canada. The cancer survival index (CSI) is superior to age standardization in measuring such progress.

Data and methods: Data are from the population-based Canadian Cancer Registry, record-linked to the Canadian Vital Statistics Death database. CSI estimates for both sexes combined were calculated as the weighted sum of the sex- and cancer-specific age-standardized net survival estimates. Sex-specific CSI estimates were calculated separately using sex-specific cancer type weights.

Results: From the 1992-to-1994 period to the 2015-to-2017 period, the five-year CSI increased 8.6 percentage points to 63.7%. It increased by 8.9 percentage points to 61.8% among males, and by 8.2 percentage points to 65.8% among females. The contribution of a cancer and sex combination to change in the CSI over time is a function of its assigned weight and changes in its age-standardized net survival. Female breast was the most influential cancer and sex combination, contributing 10.1% to the overall increase, followed by prostate (8.2%) and female lung (7.3%). The increase in the index since the 2005-to-2007 period was most impacted by lung cancer among both females (11.1%) and males (9.4%). While prostate cancer survival increased over the entire study period, it has recently decreased, resulting in a counterproductive 8.1% contribution since the 2005-to-2007 period.

Interpretation: Steady progress has been made in overall cancer survival in Canada since the early 1990s. Female breast cancer has contributed the most to this progress overall, but more recently female lung cancer has been the most influential.

查看原文本刊更多论文

癌症生存指数:衡量癌症生存的进展，以帮助评估加拿大的癌症控制工作。

背景:加拿大尚未对所有癌症类型合并后的癌症生存进展进行全面评估。癌症生存指数(CSI)在衡量这一进展方面优于年龄标准化。数据和方法:数据来自以人口为基础的加拿大癌症登记处，记录与加拿大生命统计死亡数据库相关联。两种性别的CSI估计值被计算为性别和癌症特定年龄标准化净生存估计值的加权总和。使用性别特异性癌症类型权重分别计算性别特异性CSI估计值。结果:1992- 1994年至2015- 2017年，5年CSI上升8.6个百分点，达到63.7%。男性为61.8%，增长8.9个百分点;女性为65.8%，增长8.2个百分点。随着时间的推移，癌症和性别组合对CSI变化的贡献是其指定重量和年龄标准化净存活率变化的函数。女性乳腺癌是影响最大的癌症和性别组合，占总增长的10.1%，其次是前列腺癌(8.2%)和女性肺癌(7.3%)。自2005年至2007年期间以来，该指数的增长在女性(11.1%)和男性(9.4%)中受到肺癌的影响最大。虽然前列腺癌的生存率在整个研究期间都有所增加，但最近却有所下降，导致2005- 2007年期间的贡献达到了适得其反的8.1%。解释:自20世纪90年代初以来，加拿大总体癌症生存率取得了稳步进展。总体而言，女性乳腺癌对这一进展的贡献最大，但最近女性肺癌的影响最大。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health Reports PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

7.30

自引率

4.00%

发文量

期刊介绍： Health Reports publishes original research on diverse topics related to understanding and improving the health of populations and the delivery of health care. We publish studies based on analyses of Canadian national/provincial representative surveys or Canadian national/provincial administrative databases, as well as results of international comparative health research. Health Reports encourages the sharing of methodological information among those engaged in the analysis of health surveys or administrative databases. Use of the most current data available is advised for all submissions.